Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Michelle Marks, DO, is a Staff physician in the Department of General Pediatrics at Cleveland Clinic's main campus. Dr. Marks holds several leadership positions, including Director of Pediatric Hospitalist Medicine, Associate Program Director of the Pediatric Residency and Director of Medical Operations at Cleveland Clinic's Children’s Hospital.
Dr. Marks earned a doctor of osteopathic medicine at Ohio University in Athens and did a pediatric internship at Doctor’s Hospital in Columbus, Ohio before coming to Cleveland Clinic for her residency where she served as chief pediatric resident. Board-certified by the American Board of Pediatrics, Dr. Marks is licensed to practice medicine in Ohio, Illinois and Michigan.
Listed in the 2006 edition of “Best Doctors in America,” Dr. Marks won a “Distinguished Teaching” award from the Division of Pediatrics and the Taylor Koose Compassionate Care award. She is a member of the American Academy of Pediatrics, the Ambulatory Pediatric Association, the Society for Hospital Meeting and the Association of Pediatric Program Directors.
One of Dr. Mark’s current research projects is studying the effect of treatment rooms on the anxiety of young hospitalized children. She is also investigating the safety and efficacy of the pentavalent rotavirus vaccine in healthy infants.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Marks's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.